Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ulcerative colitis
Pharma
Teva's 1st R&D day lets CEO bask in innovative drug refresh
TD Cowen analysts left Teva's first R&D day this week feeling “increasingly confident” in the firm’s direction.
Fraiser Kansteiner
,
Donavyn Coffey
Nov 13, 2026 11:16am
Lilly says it's setting 'higher bar' in IBD with Omvoh post-hoc
Oct 15, 2026 11:00am
J&J pins high hopes on Icotyde amid strong debut in psoriasis
Oct 13, 2026 11:16am
Durable IBD remission remains an unmet need: survey
Jul 24, 2026 2:07pm
Olixir NY teams with Crohn's & Colitis Foundation on new PSA
Jun 11, 2026 8:38am
Abivax hires Takeda alum as CCO to access Entyvio expertise
Mar 24, 2026 1:30pm
